Tenaya Therapeutics, Inc.
TNYA
$0.4912
$0.03066.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 29.21M | 31.82M | 33.29M | 33.74M | 33.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 115.95M | 122.74M | 126.95M | 131.23M | 131.19M |
| Operating Income | -115.95M | -122.74M | -126.95M | -131.23M | -131.19M |
| Income Before Tax | -111.13M | -117.23M | -120.74M | -124.58M | -124.08M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -111.13 | -117.23 | -120.74 | -124.58 | -124.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -111.13M | -117.23M | -120.74M | -124.58M | -124.08M |
| EBIT | -115.95M | -122.74M | -126.95M | -131.23M | -131.19M |
| EBITDA | -107.48M | -114.18M | -118.31M | -122.52M | -122.51M |
| EPS Basic | -1.31 | -1.44 | -1.54 | -1.65 | -1.69 |
| Normalized Basic EPS | -0.82 | -0.90 | -0.96 | -1.03 | -1.05 |
| EPS Diluted | -1.32 | -1.45 | -1.54 | -1.65 | -1.69 |
| Normalized Diluted EPS | -0.82 | -0.90 | -0.96 | -1.03 | -1.05 |
| Average Basic Shares Outstanding | 339.26M | 326.95M | 314.71M | 302.40M | 294.52M |
| Average Diluted Shares Outstanding | 339.26M | 326.95M | 314.71M | 302.40M | 294.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |